Biography
He completed his residency in Ophthalmology at Baylor College of Medicine, clinical fellowship in Corneal Diseases at the Bascom Palmer Eye Institute, postdoctoral research fellowship in Virology & Molecular Biology and Infectious Diseases at St. Jude Children?s Research Hospital, and Masters of Public Health degree at the University of Oklahoma.
Personal Statement
I am dedicated to improving the quality of life for every person with vision loss, and particularly those who may be otherwise underserved, and to growing diversity, equity, and inclusion in his profession of Ophthalmology.
Areas of Specialty
Infectious eye disease
Ocular chemical injury
Stevens Johnson syndrome
Restoration of corneal blindness with the Boston keratoprosthesis.
Education
2003-2007 Masters in Public Health (Biostatistics), OU College of Public Health, Oklahoma City, OK
1993-95 Postdoctoral Research Associate, Departments of Virology & Molecular Biology and Infectious Diseases, St. Jude Children?s Research Hospital, Memphis, Tennessee 1992-93 Clinical Fellow, Cornea and External Diseases, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida 1989-92 Residency, Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas
1988-89 Internship, St. Joseph?s Hospital, Houston, Texas
1984-88 M.D. Baylor College of Medicine, Houston, Texas
1982-84 (premed) New York University, New York, New York
1975-78 B.A. Hampshire College, Amherst, Massachusetts
Certifications
1993 Diplomat: American Board of Ophthalmology
Achievements & Awards
Recipient of the Alcon Research Institute Award
Four awards from Research to Prevent Blindness.
Trained over 70 clinical cornea fellows and mentored over 20 medical students under-represented in medicine.
Gender
Male
Languages
- English
Research and Scholarship
He is internationally known and respected for his work on viral genomics and pathogenesis, and on development and use of the Boston keratoprosthesis for severe corneal blindness. His basic research program on adenovirus pathogenesis and evolution has been continuously funded by the NIH since 1996, and his current funding runs through 2027. He also invented and patented a new, low-cost keratoprosthesis, the ?Lucia?, to address blindness in low resource countries.